Melissa Kijewski, DO
Family Medicine · South Charleston, WVNPI 1124477138
Payments from drug & device makers
Across 135 payments — averaging $20.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$351
- AbbVie$348
- Novo Nordisk$254
- Johnson & Johnson$205
- Amgen$175
- Boehringer Ingelheim$170
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,824100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 17 | $351 |
| AbbVie | 21 | $348 |
| Novo Nordisk | 10 | $254 |
| Johnson & Johnson | 2 | $205 |
| Amgen(2 entities) | 9 | $175 |
| Boehringer Ingelheim | 10 | $170 |
| Dexcom, Inc. | 7 | $151 |
| Sanofi-aventis U.S. LLC | 1 | $119 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $116 |
| Abbott | 6 | $108 |
| Xeris Pharmaceuticals, Inc. | 5 | $95 |
| Exact Sciences | 4 | $92 |
| AstraZeneca | 6 | $88 |
| Amneal Pharmaceuticals LLC | 5 | $82 |
| GSK | 5 | $69 |
| Astellas Pharma US Inc | 2 | $45 |
| Pfizer | 2 | $44 |
| Tactile Systems Technology Inc | 1 | $40 |
| Nevro Corp. | 2 | $38 |
| Viatris Specialty LLC | 2 | $33 |
| Organon | 1 | $29 |
| Lilly USA, LLC | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $20 |
| Novartis | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$125
- SOLIQUA 100/33$119
How this compares
$2,824 in reported general payments places this provider in the 80th percentile of 843 family medicine providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 101 | $136,751 |
| Enbrel SureclickEtanercept | 14 | $103,275 |
| MounjaroTirzepatide | 85 | $94,412 |
| JanuviaSitagliptin Phosphate | 72 | $93,042 |
| EliquisApixaban | 68 | $82,762 |
| JardianceEmpagliflozin | 30 | $45,777 |
| VraylarCariprazine Hcl | 17 | $29,826 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 24 | $27,459 |
| LinzessLinaclotide | 18 | $26,478 |
| EntrestoSacubitril/Valsartan | 17 | $25,955 |
| VascepaIcosapent Ethyl | 30 | $22,039 |
| Repatha SureclickEvolocumab | 22 | $20,872 |
| XareltoRivaroxaban | 13 | $20,700 |
| Spiriva HandihalerTiotropium Bromide | 28 | $17,522 |
| SymbicortBudesonide/Formoterol Fumarate | 45 | $16,361 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $254 | $136,751101 claims |
| Lilly USA, LLCMounjaro, Trulicity | $26 | $109,96999 claims |
| PfizerEliquis | $44 | $82,76268 claims |
| AbbVieVraylar, Linzess, Synthroid | $348 | $59,05961 claims |
| Boehringer IngelheimJardiance | $170 | $45,77730 claims |
| GSKTrelegy Ellipta | $69 | $27,45924 claims |
| NovartisEntresto | $18 | $25,95517 claims |
| Johnson & JohnsonXarelto | $205 | $20,70013 claims |
| AstraZenecaSymbicort | $88 | $16,36145 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid | $82 | $6,750324 claims |
| Astellas Pharma US IncMyrbetriq | $45 | $5,31811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 843 family medicine providers in West Virginia.
Other family medicine in South Charleston
- Julie DetempleSouth Charleston$129K
- Kenneth AdkinsSouth Charleston$17K
- Chad TurnerSouth Charleston$11K
- Michelle BurdetteSouth Charleston$9K
- Howard LaffertySouth Charleston$8K
- John FrameSouth Charleston$8K
- Wilbur SineMorgantown$179K
- Dorian WilliamsMorgantown$169K
- Clemente DiazRichwood$127K
- John CornellHuntington$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.